-- 18,500m2 area being remade into state-of-the-art facility dedicated to life sciences and pharmaceuticals to provide higher ...

"SK pharmteco announces $260m production expansion in South Korea" was originally created and published by Pharmaceutical ...

BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading MedTech company focused on the development, manufacture and commercialization of placental-derived biologics, announces ...

The plaintiff, Skylar Williams, accused Galderma Laboratories of producing a skin-care line that contains benzene. In one of ...

Company is aligned with the FDA on next steps for a 351(k) regulatory pathway to approval for ABP-450 (prabotulinumtoxinA) as a biosimilar utilizing BOTOX® (onabotulinumtoxinA) as the reference ...

SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a major expansion of its small molecule and peptide ...

Karnataka: Biocon Biologics has announced that the US Food and Drug Administration (USFDA) has completed a cGMP inspection at ...

PRNewswire Bengaluru Karnataka [India] September 30 Healthium Medtech a global player in medical devices focused on products ...

Shares of Biocon have surged 44% in 2024 to date and 30% over the past two years, with the company currently holding a market ...

That's why we made it our mission to identify the absolute best cortisol supplements on the market in 2024. We've analyzed ...

Kincell Bio, a cell therapy-focused cGMP contract development and manufacturing organization (CDMO), today announced that it ...

His journey is marked by a series of impactful roles where his leadership, technical skills, and dedication to excellence ...